Interventions in antipsychotics-treated patients with cardiometabolic risk factors or metabolic syndrome

被引：1
|
作者：
Larsen, J. [1 ]
Holdrup, M. [2 ]
Christensen, B. [3 ]
Sigalin, C. [4 ]
Nilsson, P. M. [5 ]
Kolb, S. [6 ]
机构：
[1] Odense Univ Hosp, Dept Psychiat, Odense C, Denmark
[2] 3MDS Pharma Serv, Copenhagen, Denmark
[3] Aalborg Psychiat Hosp, Dept Psychiat, Aalborg, Denmark
[4] Ryhov Cty Hosp, Dept Psychiat, Jonkoping, Sweden
[5] Malmo Univ Hosp, Dept Clin Sci, Malmo, Sweden
[6] Pfizer, Med Affairs, Walton Oaks, England
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2008年 / 18卷
关键词：
D O I：
10.1016/S0924-977X(08)70648-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S440 / S441
页数：2
相关论文
共 50 条
  • [31] Inflammatory cytokines and features of the metabolic syndrome among patients treated with atypical antipsychotics
    Alméras, N
    Demers, MF
    Villeneuve, J
    Roy, MA
    Bouchard, RH
    Després, JP
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 350 - 351
  • [32] Successful implementation of cardiometabolic monitoring of patients treated with antipsychotics REPLY
    Lambert, Timothy J. R.
    MEDICAL JOURNAL OF AUSTRALIA, 2009, 191 (09) : 519 - 519
  • [33] Metabolic Syndrome and Cardiovascular Risk in People Treated with Long-Acting Injectable Antipsychotics
    Sanchez-Martinez, Vanessa
    Romero-Rubio, Dolores
    Jose Abad-Perez, Maria
    Amparo Descalzo-Cabades, Maria
    Alonso-Gutierrez, Sofia
    Salazar-Fraile, Jose
    Montagud, Vicente
    Facila, Lorenzo
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2018, 18 (04) : 379 - 387
  • [34] Cardiometabolic Risk Factors Related to Atrial Fibrillation and Metabolic Syndrome in the Pakistani Population
    Rafaqat, Saira
    Sharif, Saima
    Naz, Shagufta
    Gluscevic, Sanja
    Mercantepe, Filiz
    Ninic, Ana
    Klisic, Aleksandra
    MEDICINA-LITHUANIA, 2024, 60 (08):
  • [35] Risk of adverse health outcome and metabolic syndrome in adolescents treated with antipsychotics: preliminary results
    Merchan-Naranjo, J.
    Giraldez-Quiroga, M.
    Moreno, C.
    Pina, L.
    Parellada, M.
    Tapia, C.
    Rodriguez, P.
    Arango, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S496 - S497
  • [36] Cardiometabolic Risk Factors, Metabolic Syndrome, and Chronic Kidney Disease Progression in Children
    Lalan, Shwetal
    Jiang, Shuai
    Ng, Derek K.
    Kupferman, Fernanda
    Warady, Bradley A.
    Furth, Susan
    Mitsnefes, Mark M.
    JOURNAL OF PEDIATRICS, 2018, 202 : 163 - 170
  • [37] Circulating microRNA Related to Cardiometabolic Risk Factors for Metabolic Syndrome: A Systematic Review
    Brandao-Lima, Paula N.
    de Carvalho, Gabrielli B.
    Payolla, Tanyara B.
    Sarti, Flavia M.
    Rogero, Marcelo M.
    METABOLITES, 2022, 12 (11)
  • [38] CARDIOMETABOLIC RISK ASSOCIATED WITH METABOLIC SYNDROME IN TYPE 2 DIABETES PATIENTS
    Torrea, M.
    Aladeazabal, N.
    Lopez Berastegui, O. L. G. A.
    Pinilla, B.
    Muino, A.
    Millan, J.
    ATHEROSCLEROSIS, 2014, 235 (02) : E237 - E238
  • [39] LOW RATES OF TREATMENT OF CARDIOVASCULAR RISK FACTORS IN PATIENTS TREATED WITH ANTIPSYCHOTICS
    van der Heijden, F.
    Steylen, P.
    Kok, H.
    Slaar, A.
    Verhoeven, W.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [40] Association between metabolic disease and cardiovascular risk in patients with schizophrenia treated with antipsychotics
    Vataire, A.
    Ferchichi, S.
    Desroziers, K.
    Cadi-Soussi, N.
    Murthy, V.
    Toumi, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S495 - S495
12345